Tag Archive | "oral cancer"

FDA Spends $36 Million on Anti-Chewing Tobacco Ad Campaign

Thursday, April 21, 2016

0 Comments

Source: www.freebeacon.com Author: Elizabeth Harrington The Food and Drug Administration is spending $36 million on an anti-chewing tobacco advertising campaign targeted at white male teenagers in the midwest. The federal agency announced Tuesday it is expanding its “Real Cost” anti-tobacco campaign to “educate rural, white male teenagers” and convince them to stop dipping. “Smokeless tobacco […]

Continue reading...

Nivolumab Improved Survival For Patients With Head and Neck Squamous Cell Carcinoma

Tuesday, April 19, 2016

0 Comments

Source: www.aacr.org Author: AACR Newsroom Staff   NEW ORLEANS — Treatment with the immunotherapeutic nivolumab (Opdivo) improved survival for patients with recurrent or metastatic head and neck squamous cell carcinoma that progressed after platinum-based chemotherapy compared with single-agent chemotherapy of the investigator’s choice, according to results from the CheckMate-141 phase III clinical trial presented here […]

Continue reading...

Minimizing Imaging for Recurrence of HPV-Associated Head & Neck Cancer

Monday, April 18, 2016

0 Comments

Source: www.journals.lww.com/oncologytimes Author: Robert H. Carlson   SCOTTSDALE, ARIZ.—Most recurrences of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) can be found through imaging and physical exams within six months after treatment, according to a study from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fla. “For most patients with HPV-associated oropharyngeal cancer who […]

Continue reading...

ASCO Urges Aggressive Efforts to Increase HPV Vaccination

Monday, April 18, 2016

0 Comments

Source: www.medscape.com Author: Zosia Chustecka   Human papillomavirus (HPV) vaccines have now been available for 10 years, but despite many medical professional bodies strongly recommending the vaccine, uptake in the United States remains low. Data from a national survey show that about 36% of girls and 14% of boys have received the full schedule of […]

Continue reading...

Merck Says FDA Accepts Its SBLA For Keytruda For Treatment Of Head & Neck Cancer

Wednesday, April 13, 2016

0 Comments

Source: www.finchannel.com Author: Fin Channel News Editorial Staff   The FINANCIAL — Merck, known as MSD outside the United States and Canada, on April 13 announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of […]

Continue reading...

Suicide: A Major Threat to Head and Neck Cancer Survivorship

Thursday, March 24, 2016

0 Comments

Source: www.jco.ascopubs.com Authors: Nosayaba Osazuwa-Peters, Eric Adjei Boakye, and Ronald J. Walker
, Mark A. Varvares   TO THE EDITOR: The article by Ringash that was recently published in Journal of Clinical Oncology provided a compelling narrative of both the improvements made in head and neck cancer survivorship, as well as the challenges created by longer-term […]

Continue reading...

The Oral Cancer Foundation’s Founder, Brian R. Hill, honored by the Global Oral Cancer Forum – International oral cancer community honor his accomplishments in the field.

Friday, March 11, 2016

0 Comments

Source: www.prnewswire.com Author: The Oral Cancer Foundation   NEWPORT BEACH, Calif., March 10, 2016 /PRNewswire-USNewswire/ — At the recent Global Oral Cancer Forum (GOCF), Brian R. Hill, Executive Director and Founder of the Oral Cancer Foundation (OCF), was honored for his work as an advocate and innovative thinker in the oral cancer arena. The GOCF organizers […]

Continue reading...

Immunotherapy Continues to Advance in Head and Neck Cancer

Monday, February 29, 2016

0 Comments

Source: www.onclive.com Author: Megan Garlapow, PhD   Concomitant administration of motolimod with cetuximab (Erbitux) increases the innate and adaptive immune response in the blood and the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC), overcoming negative prognostic biomarkers of cetuximab therapy alone, according to the biomarker data from a recent phase Ib clinical […]

Continue reading...

Cancer-causing HPV plummeted in teens since vaccine, study finds

Tuesday, February 23, 2016

0 Comments

Source: www.cnn.com Author: Sarina Storres   (CNN)The human papillomavirus vaccine was first recommended for adolescent girls in the United States in 2006. Since that time, the prevalence of the cancer-causing virus has been dropping among young women, according to a new study. Researchers at the Centers for Disease Control and Prevention compared the rates of […]

Continue reading...

ASTRO: Study maps distinct molecular signatures of HPV-positive throat cancer patients by smoking status

Monday, February 22, 2016

0 Comments

Source: www.dotmed.com Author: ASTRO   Scottsdale, Ariz., February 18, 2016, ASTRO — Throat cancer patients exposed to both human papillomavirus (HPV) and tobacco smoke demonstrate a pattern of mutations along several key cancer genes, according to research presented today at the 2016 Multidisciplinary Head and Neck Cancer Symposium. These distinct molecular profiles of heavy and […]

Continue reading...